 |
|
|
| |
Risk of Total Non-hepatic Cancer Following Treatment
for HCV Infection with Direct-acting Antiviral Agents
|
| |
| |
Reported by Jules Levin
EASL 2018 April 14 Paris France
Anand P. Chokkalingam1,2, Amanda W. Singer1, Laura E. Telep1, Anu O. Osinusi1, Diana M. Brainard1
1Gilead Sciences Inc., Foster City, CA, USA; 2School of Public Health, University of California, Berkeley
|
| |
|
|
|
|
|
